- Home
- LAKE vs BIOA Comparison
LAKE vs BIOA Comparison
Compare LAKE & BIOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LAKE
- BIOA
- Stock Information
- Founded
- LAKE 1982
- BIOA 2015
- Country
- LAKE United States
- BIOA United States
- Employees
- LAKE N/A
- BIOA N/A
- Industry
- LAKE Industrial Specialties
- BIOA Biotechnology: Pharmaceutical Preparations
- Sector
- LAKE Health Care
- BIOA Health Care
- Exchange
- LAKE Nasdaq
- BIOA Nasdaq
- Market Cap
- LAKE 161.5M
- BIOA 175.7M
- IPO Year
- LAKE 1986
- BIOA 2024
- Fundamental
- Price
- LAKE $15.95
- BIOA $7.24
- Analyst Decision
- LAKE Strong Buy
- BIOA Hold
- Analyst Count
- LAKE 3
- BIOA 4
- Target Price
- LAKE $25.00
- BIOA $9.00
- AVG Volume (30 Days)
- LAKE 98.5K
- BIOA 663.4K
- Earning Date
- LAKE 12-04-2025
- BIOA 11-06-2025
- Dividend Yield
- LAKE 0.75%
- BIOA N/A
- EPS Growth
- LAKE N/A
- BIOA N/A
- EPS
- LAKE N/A
- BIOA N/A
- Revenue
- LAKE $191,631,000.00
- BIOA $5,917,000.00
- Revenue This Year
- LAKE $29.73
- BIOA N/A
- Revenue Next Year
- LAKE $8.45
- BIOA N/A
- P/E Ratio
- LAKE N/A
- BIOA N/A
- Revenue Growth
- LAKE 39.13
- BIOA N/A
- 52 Week Low
- LAKE $12.76
- BIOA $2.88
- 52 Week High
- LAKE $27.28
- BIOA $22.93
- Technical
- Relative Strength Index (RSI)
- LAKE 48.80
- BIOA 60.17
- Support Level
- LAKE $15.90
- BIOA $7.09
- Resistance Level
- LAKE $17.72
- BIOA $7.88
- Average True Range (ATR)
- LAKE 0.67
- BIOA 0.50
- MACD
- LAKE -0.10
- BIOA -0.01
- Stochastic Oscillator
- LAKE 15.49
- BIOA 59.28
About LAKE Lakeland Industries Inc.
Lakeland Industries Inc manufactures and sells safety garments and accessories for the industrial protective clothing market. Its product segments include Disposables, Chemicals, Fire, Gloves, High Visibility, High-Performance Wear, and Wovens. Its customers include integrated oil, chemical/petrochemical, utilities, automobile, steel, glass, construction, smelting, munition plants, janitorial, pharmaceutical, and mortuaries, as well as scientific and medical laboratories. Its geographical segments include the United States, Latin America, Canada, Asia, Mexico, Europe (United Kingdom), and Other Foreign.
About BIOA BioAge Labs Inc. Common Stock
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.